| 4WYJ: reference: Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin., Richter M, Yumul R, Wang H, Saydaminova K, Ho M, May D, Baldessari A, Gough M, Drescher C, Urban N, Roffler S, Zubieta C, Carter D, Fender P, Lieber A, Mol Ther Methods Clin Dev. 2015 Mar 11;2:15005. doi: 10.1038/mtm.2015.5., eCollection 2015. PMID: 26029716 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).